Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 7/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 7/20 | 0.35 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.31 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.31 |
| ▸ | CPT2 | P23786 | 1/20 | 0.30 |
| ▸ | CPT1A | P50416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4157361 | 1.00 | MTNR1A (0.35) | MTNR1AMTNR1BPRKCAMMP12CNR2 | |
| SCHEMBL4145150 | 0.94 | KCNH2 (0.35) | MTNR1AMTNR1BPRKCAMMP12 | |
| SCHEMBL4145154 | 0.94 | KCNH2 (0.35) | MTNR1AMTNR1BPRKCAMMP12 | |
| SCHEMBL4156042 | 0.94 | PRKCA (0.38) | MTNR1AMTNR1BPRKCAMMP12PRMT5 | |
| SCHEMBL4156040 | 0.94 | PRKCA (0.38) | MTNR1AMTNR1BPRKCAMMP12PRMT5 | |
| SCHEMBL4149818 | 0.93 | GHSR (0.38) | PRKCAMMP12CNR2KDM4EALDH1A1 | |
| SCHEMBL4149821 | 0.93 | GHSR (0.38) | PRKCAMMP12CNR2KDM4EALDH1A1 | |
| SCHEMBL4157358 | 0.91 | ALDH1A1 (0.38) | MTNR1AMTNR1BCNR2PRMT5WDR77 | |
| SCHEMBL4157356 | 0.91 | ALDH1A1 (0.38) | MTNR1AMTNR1BCNR2PRMT5WDR77 | |
| SCHEMBL4151954 | 0.91 | PRMT5 (0.33) | PRKCAMMP12PRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090136449-A1 | Tetracyclic Indole Derivatives as Antiviral Agents | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2009-05-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090136449-A1 | Tetracyclic Indole Derivatives as Antiviral Agents | IDO1, IDO2, ZC3HAV1 | MTNR1A 45/4885MTNR1B 139/4885PRKCA 4320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.